[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"beta-blocker-toxicity\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:beta-blocker-toxicity":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":5},"100416613","phase-3-clinical-study-evaluating-beta-blockers-use-and-fracture-risk-in-patients-with-primary-osteoporosis-100416613",false,"NCT04704947","Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis","Clinical Study Evaluating Selective or Nonselective Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis","Inclusion Criteria:\n\n* • Male \\& female osteoporotic patient aged ≥ 50 years\n\n  * Hypertensive \\& normotensive patients\n  * BMD T-score ≥ 2.5 or more SD below peak bone mass\n\nExclusion Criteria:\n\n* Patients on drugs that may improve osteoporosis disease state such as:\n\n  * Angiotensin converting enzyme inhibitor (ACEI) or Angiotensin receptor blockers (ARBs), Thiazide diuretic, Nitrates, Spironolactone, Statins.\n\nPatients on drugs that may worsen osteoporosis disease state such as:\n\n• Corticosteroids, Loop diuretics, Anticonvulsants, Antidepressants, Aromatase inhibitors, Thyroid replacement therapy and Proton pump inhibitors.","ALL","50 Years",{"count":19,"type":20},50,"ESTIMATED","INTERVENTIONAL",[23],"PHASE3","Clinical study evaluating selective or nonselective beta blockers use and fracture risk in patients with primary osteoporosis",[26],"Beta Blocker Toxicity","RECRUITING","2021-01-09",{"date":30,"type":31},"2021-01-12","ACTUAL",{"date":33,"type":31},"2017-10-01",{"date":35,"type":20},"2030-10-01",{"name":37,"class":38},"Sherief Abd-Elsalam","OTHER"]